Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0000897069-12-000295
Filing Date
2012-06-25
Accepted
2012-06-22 17:39:10
Documents
1
Effectiveness Date
2012-06-25
Items
Item 06: Rule 506

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 12757
  Complete submission text file 0000897069-12-000295.txt   13898
Mailing Address 324 SOUTH HYDE PARK AVE SUITE 350 TAMPA FL 33606
Business Address 324 SOUTH HYDE PARK AVE SUITE 350 TAMPA FL 33606 813.864.2554
ACCENTIA BIOPHARMACEUTICALS INC (Filer) CIK: 0001310094 (see all company filings)

EIN.: 000000000 | State of Incorp.: FL | Fiscal Year End: 0930
Type: D | Act: 33 | File No.: 021-180216 | Film No.: 12923244
SIC: 2834 Pharmaceutical Preparations